Objective:
To explore innovative strategies and emerging technologies for managing myopia, addressing the urgent need as its prevalence increases globally.
Approach:
- Ortho-k and multifocal soft lenses effectively slow myopia progression, supported by recent studies.
- Combination therapy with atropine and specialty lenses may improve treatment outcomes, as indicated by emerging research.
- Emerging technologies like biosensor-embedded lenses and AI-driven predictive algorithms could personalize myopia management, enhancing treatment efficacy.
- Need for more research on the long-term effects of combination therapies, particularly regarding patient outcomes.
- Complex engineering challenges, such as miniaturization and power supply, hinder the widespread adoption of smart contact lenses.
- Concerns regarding safety and efficacy of light-based therapies in children, necessitating further investigation.
- Wildsoet et al, 2019
- Zhang et al, 2024
- Tsai et al, 2022
- Liu et al, 2024
- Xu et al, 2024
- Zhang and Zou, 2024
Key Findings:
Interpretation:
The integration of innovative therapies and technologies is crucial for advancing myopia management, emphasizing a shift towards personalized treatment plans that cater to individual patient needs.
Limitations:
Conclusion:
As research progresses, the combination of traditional and innovative approaches may redefine myopia management, leading to more effective and individualized care, underscoring the need for continued exploration in this field.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.